Telosaf-MT 40/50 combines Telmisartan (40 mg) and Metoprolol Succinate (50 mg) for effective management of hypertension and heart-related conditions. Telmisartan an angiotensin II receptor blocker (ARB) helps relax blood vessels and lower blood pressure while Metoprolol a beta-blocker reduces heart rate and workload on the heart. This synergistic formulation provides comprehensive cardiovascular support improving heart health and reducing the risk of complications associated with high blood pressure.
Reviews
There are no reviews yet.